Coastlands Capital LP - 04 Dec 2025 SCHEDULE 13G Report for Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

Filing Manager
Coastlands Capital LP
Reporting Manager
Coastlands Capital LP
Security
Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
XLO
Shares outstanding
53.5M shares
Disclosed Ownership
5.35M shares
Ownership
9.99%
Form type
SCHEDULE 13G
Filing time
11 Dec 2025, 17:55:21 UTC
Date of event
04 Dec 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Coastlands Capital LP 9.99% 5.35M 0 5.35M /s/ Mark Shamia Chief Operating Officer of the General Partner, Coastlands Capital LLC
Coastlands Capital Partners LP 9.99% 5.35M 0 5.35M /s/ Mark Shamia Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Coastlands Capital GP LLC 9.99% 5.35M 0 5.35M /s/ Mark Shamia Chief Operating Officer
Coastlands Capital LLC 9.99% 5.35M 0 5.35M /s/ Mark Shamia Chief Operating Officer
Matthew D. Perry 9.99% 5.35M 0 5.35M /s/ Matthew D. Perry Reporting person